Newborn Metabolic Screening Market Size is Projected to Grow from US$ 295.7 Million in 2022 to US$ 757.9 Million by 2032, Exhibiting a CAGR of 8.9% | Persistence Market Research
22 janv. 2024 03h15 HE | Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newborn Metabolic Screening Market Overview: The Newborn Metabolic Screening Market is a crucial component of newborn healthcare, aimed at detecting...
Durin Technologies, Inc., an innovator in neurodegenerative disease diagnostic test development and commercialization, received funding of $3.5 million led by Breakthrough Diagnostics, LLC.
Durin Technologies Receives Additional Funding to Accelerate Growth
05 déc. 2023 10h00 HE | Durin Technologies
Stratford, NJ, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Durin Technologies, Inc., an innovator in neurodegenerative disease diagnostic test development and commercialization, today announced funding of...
Dignity Health St. J
Dignity Health St. Joseph’s Hospital and Medical Center launches new initiative to address health disparities of African Americans with chronic kidney disease PHOENIX, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Dignity Health St. Joseph’s Hospital and Medical Center has launched a new initiative to address race-based algorithms in early diagnosis of chronic kidney...
TODAY: CMS Controver
TODAY: CMS Controversy, Rep. Eshoo, Nationally Recognized Scientists to Take Center Stage at UsAgainstAlzheimer’s National Summit
12 oct. 2022 12h27 HE | UsAgainstAlzheimer's
Washington, DC, Oct. 12, 2022 (GLOBE NEWSWIRE) -- With the federal government’s decision to deny Medicare coverage of an entire class of Alzheimer’s treatments, as well as the promising clinical...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights Offering
12 janv. 2022 16h41 HE | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it commenced its previously announced fully...
LOGO.jpg
Interpace Biosciences Announces Executive Transition: Jack Stover to Retire as President and Chief Executive Officer Thomas Burnell Appointed as Successor
25 nov. 2020 08h12 HE | Interpace Biosciences, Inc.
Parsippany, NJ, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) today announced that Jack Stover, President & Chief Executive Officer, will retire effective December...
Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care
11 févr. 2020 09h00 HE | Cognoa
PASADENA and PALO ALTO, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Autism Learning Partners ("ALP"), a national leader in the treatment of autism and other developmental disabilities, and Cognoa, the...
DiamiR Announces Oral Presentation at AD/PD(TM) 2017
29 mars 2017 08h02 HE | DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 29, 2017) - DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil...